“Mind The Gap(s) – Moving Novel Drugs from Bench to Bedside”
We’re thrilled to announce the release of our White Paper on drug development in endometriosis and adenomyosis. This report, titled “Mind The Gap(s) – Moving Novel Drugs from Bench to Bedside”, provides a strategic roadmap for innovative treatments in these common and often devastating diseases.
Download the White Paper
This report features:
• In-depth analysis of the challenges in developing new therapies
• Exploration of opportunities for non-hormonal, disease-modifying treatments
• Insights into transforming reproductive health outcomes for affected women
Our White Paper delves into the complexities of these often overlooked conditions which affect millions of women worldwide. By identifying critical gaps in research and development, it aims to catalyze innovations that significantly improve the quality of life for those suffering from endometriosis and adenomyosis.
Why It Matters:
• Endometriosis and adenomyosis affect over 10% of women of reproductive age
• Both conditions can cause severe pain, heavy bleeding, and fertility issues
Many thanks to our partner Catenion and to the many academic thought leaders, industry experts, entrepreneurs, and patients who contributed to this effort! Their valuable input and feedback have made this White Paper possible.
Download the report now and join us in driving meaningful change!